SEC Form 4 · accession 0001127602-17-027538
LEXICON PHARMACEUTICALS, INC. · LXRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sam L Barker
Director
Period of report
Sep 15, 2017
Accepted (ET)
Sep 18, 2017 · 6:36 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 15, 2017 | P | 1,000 | $12.50 | A | 25,623 | D |
Table II — derivative securities
No Table II lines on this filing.